Drew Moghanaki, MD, MPH
banner
drewmoghanaki.bsky.social
Drew Moghanaki, MD, MPH
@drewmoghanaki.bsky.social

MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles

https://www.uclahealth.org/radonc/drew-moghanaki

Physics 69%
Public Health 13%

Is there a prize for finding toxicity? Is that the ultimate goal? It sure seems to be that way for many academic clinicians in this specialty.

I believe our patients want us to have a different objective other than hunting for harms.

Why do #radonc articles start with the T word? Who started this self-defeatist approach and why isn’t anyone talking about how this makes the R word even scarier?

Do something.